Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes

J Xiong, H Chi, G Yang, S Zhao, J Zhang… - Frontiers in …, 2023 - frontiersin.org
B cells occupy a vital role in the functioning of the immune system, working in tandem with T
cells to either suppress or promote tumor growth within the tumor microenvironment (TME) …

Pharmacogenomics: driving personalized medicine

W Sadee, D Wang, K Hartmann, AE Toland - Pharmacological reviews, 2023 - ASPET
Personalized medicine tailors therapies, disease prevention, and health maintenance to the
individual, with pharmacogenomics serving as a key tool to improve outcomes and prevent …

NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing

W Feng, JC Beer, Q Hao, IS Ariyapala… - Nature …, 2023 - nature.com
The blood proteome holds great promise for precision medicine but poses substantial
challenges due to the low abundance of most plasma proteins and the vast dynamic range …

Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation

K Wang, X Wang, Q Pan, B Zhao - Molecular cancer, 2023 - Springer
Pancreatic cancer (PC) is one of the most common malignancies. Surgical resection is a
potential curative approach for PC, but most patients are unsuitable for operations when at …

New insights into the correlations between circulating tumor cells and target organ metastasis

Q Zhan, B Liu, X Situ, Y Luo, T Fu, Y Wang… - … and Targeted Therapy, 2023 - nature.com
Organ-specific metastasis is the primary cause of cancer patient death. The distant
metastasis of tumor cells to specific organs depends on both the intrinsic characteristics of …

Recent trends in biosensing and diagnostic methods for novel cancer biomarkers

J Rao Bommi, S Kummari, K Lakavath, RA Sukumaran… - Biosensors, 2023 - mdpi.com
Cancer is one of the major public health issues in the world. It has become the second
leading cause of death, with approximately 75% of cancer deaths transpiring in low-or …

Prospects in Cancer Diagnosis: Exosome-Chip for Liquid Biopsy

KR Khondakar, MA Kachouei, FE Erukainure… - ECS Sensors …, 2023 - iopscience.iop.org
A liquid biopsy combined with an exosome-chip (EC) is an important detection tool for early
cancer diagnosis. Exosomes have a crucial function in the exchange of information between …

Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review

G Di Sario, V Rossella, ES Famulari, A Maurizio… - Frontiers in …, 2023 - frontiersin.org
In the last years, liquid biopsy gained increasing clinical relevance for detecting and
monitoring several cancer types, being minimally invasive, highly informative and replicable …

Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction

R Song, F Liu, Y Ping, Y Zhang, L Wang - Biomarker Research, 2023 - Springer
Immune checkpoint inhibitors (ICIs) have dramatically enhanced the treatment outcomes for
diverse malignancies. Yet, only 15–60% of patients respond significantly. Therefore …

Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids

L Huang, Y Xu, N Wang, K Yi, X Xi, H Si… - Small …, 2024 - Wiley Online Library
Basic and clinical cancer research requires tumor models that consistently recapitulate the
characteristics of prima tumors. As ex vivo 3D cultures of patient tumor cells, patient‐derived …